CClinicalTrials.gg
CompletedNCT06560918Updated Aug 5, 2026Results posted

Self-efficacy-based Auditory Rehabilitation With Over-the-Counter Hearing Aids

An interventional study of hearing aids in Hearing Loss, Sensorineural, sponsored by University of Arkansas. Completed at 1 site in United States. Open to participants aged 18 Years to 85 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-05.

Sponsored by University of Arkansas · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
5
Allocation
Not applicable
Ages
18 Years to 85 Years
Sex
All
01

Study summary

This goal of this study is to learn if a new audiology treatment process called the self-efficacy-based auditory rehabilitation (SEBAR) can improve confidence and success with over-the-counter (OTC) hearing aids.

The main questions it aims to answer are:

  • Can the SEBAR improve participants' confidence related to managing their over-the-counter hearing aids?
  • Can the SEBAR improve participants' willingness to adopt over-the-counter hearing aids, their satisfaction, quality of life, and their emotional state? Researchers will compare these outcomes of the SEBAR with and without wearing OTC hearing aids.

Participants will:

  • Visit for one appointment to complete a few questionnaires without OTC hearing aids
  • Wear a pair of ITC hearing aids for a week and use an app to answer questions about their experiences
  • Visit for a second appointment to complete the same questionnaires with OTC hearing aids.
Read the detailed description

The proposed study will use a single-arm pre-post intervention research design to achieve both the aims. Participants will complete two appointments. Assessments in the first appointment will serve as the baseline (unaided). This will be followed by a week of OTC HA use and SEBAR implementation in their natural listening situations and the outcome measures will be completed again in appointment 2 (aided) to reflect the impact of wearing OTC HAs. Scores on the outcome measures will be compared between the unaided and the aided conditions to answer both the aims. Both the appointments in the proposed study will be completed in the shared and dedicated research spaces in the Department of Audiology and Speech Pathology, College of Health Professions at the University of Arkansas for Medical Sciences. The research proposal will be submitted for the university's Institutional Review Board's approval Upon arrival participants will complete the consent process in which the PI will describe in detail all study procedures, risks and benefits of the study, and the lack of negative consequences should the participant choose to withdraw from the study or cease participation during data collection. Once the consent form has been signed, the participant will complete two appointments.

Appointment 1: For each interested participant, a standard audiometric procedure will be completed to confirm their eligibility. Once the eligible participants consent, preliminary measures will be completed. Participants will then complete the unaided baseline outcome measures of hearing aid self-efficacy, willingness to adopt HAs, expected HA satisfaction, current emotional state, and quality of life. At this time, OTC HAs will be fitted to the participants and they will receive the SEBAR. Participants will be instructed to use the HAs for at least 4 hours every day for the next week. Finally, the EMA app will be installed on their phone and its use at home will be demonstrated by the researcher.

Appointment 2: At this appointment, data from the EMA app during the one-week field trial will be stored. HAs will be tested using the Verifit 2 to verify if they are providing the required amount of amplification at the participants' preferred settings. All the outcome measures conducted will be repeated to reflect the outcomes after using the OTC HAs for a week.

02

Conditions studied

  • Hearing Loss, Sensorineural
03

In context

Hearing Loss, Sensorineural

371 studies on the registry are indexed under Hearing Loss, Sensorineural; 112 are open to participants now.

This study's enrollment of 5 is below the median of 32 across 264 interventional studies indexed under Hearing Loss, Sensorineural.

Browse Hearing Loss, Sensorineural studies →

Lead sponsor

University of Arkansas is the lead sponsor of 391 studies on the registry; 39 are open to participants now.

Of its 37 completed or terminated interventional studies of FDA-regulated products, 34 (92%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Between 18 - 85 years old

    • Non-fluctuating, adult-onset, bilateral mild-to-moderate sensorineural hearing loss (average hearing thresholds for 500-3000Hz between 25- and 60-dB HL and no more than 10 dB difference between ears).
    • No previous experience with hearing aids
    • English as their first language with good self-reported health

Exclusion criteria

Exclusion Criteria:

  • Any reported history of outer or middle ear pathologies • No participants will be excluded based on their gender, race/ethnicity.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
5 participants (actual)

Study arms

  • Experimental
    Pre-post single arm design

    Participants will wear the hearing aids for a week while receiving the SEBAR. Outcomes will be assessed with and without hearing aids.

    Device: hearing aids

Interventions

  • Devicehearing aids

    OTC devices for a week

06

What researchers measure

Primary outcomes

  1. Percentage of Total Confidence

    The Measure of Audiologic Rehabilitation Self-Efficacy for Hearing Aids (MARS-HA), referred to as MARSHA, is a 24-item, validated, self-report questionnaire used to assess an individual's confidence (self-efficacy) in their ability to use and manage hearing aids. Participants rated their confidence for each item (0 - 100%) and the average percentage across all items was calculated as the percentage of total confidence. Scores between pre- and post-conditions were compared and reported here.

    Time frame: 1 week

Secondary outcomes

  1. Total Readiness Score on the URICA Scale

    Participants' readiness to adopt HAs was assessed using the 32-item modified University of Rhode Island Change Assessment (URICA). Each item presents a statement that asks about how ready a person is to move along in their hearing-health journey and adopt a treatment such as HAs. Participants respond to each item using a 5-point scale ranging from strongly disagree (1 point) to strongly agree (5 points). Items represent the stages of change (precontemplation, contemplation, preparation, action). Total readiness score (Readiness for change) is calculated by adding the scores representing the stages contemplation, preparation, action and subtracting this from scores on the items representing the precontemplation stage. The range of total readiness for change score is -2 to 14. Higher score represents higher readiness to adopt HAs, with scores of 11 or more is considered appropriate for someone to have the readiness to taken action to get hearing aids.

    Time frame: 1 week

  2. Hearing Aid Satisfaction on SADL Average Score

    The Satisfaction with Amplification in Daily Life (SADL) Scale is a standardized, self-report instrument used to assess patient satisfaction with hearing aid use, including perceived benefit, usability, and psychosocial impact. It has 15 items in 4 subscales (Positive Effect, Service and Cost, Negative Features, Personal Image). For this study, only average score across all items was calculated. For each item participants respond the frequency (how frequently the said outcome in the item happens with them or true for them). Average frequency score (ranging from 1-5) across all items is used for analysis. The range of possible score is 1 to 7. Higher scores indicate greater satisfaction with hearing aids (better outcome). Lower scores indicate lower satisfaction or greater perceived difficulty with hearing aids (poorer outcomes).

    Time frame: 1 week

  3. Emotional State Total Score

    Participants' change in emotional state will be assessed using the, 20-item, Positive and Negative Affect Schedule-Short Form (PANAS-SF). Participants respond to each item on a 5-point Likert scale ranging from "very slightly or not at all" to "extremely." Participants are asked to read each word and indicate the extent (intensity) to which they feel that way before/after wearing HAs. Positive and negative affective scores will be computed by calculating the sum of the items included for each of these two subscales. For this study, the final emotional state average score was calculated by subtracting the negative state score from the positive state score for each participant. Total possible range of scores would be -40 to +40. A positive emotional state total score indicated that the participant reported greater positive emotional states than negative emotional states.

    Time frame: 1 week

  4. Hearing-related Quality of Life Total Score

    A one-item hearing-related quality of life question wase used. The question asked about participants' current quality of life compared to before. The scale ranges from "a very great deal worse" (-7) to "a very great deal better" (7). An absolute change of 2 or more is considered clinically relevant in audiology. Higher positive values indicate improvements in hearing- related QOL and higher negative values indicate reduced hearing related QOL.

    Time frame: 1 week

07

Results

Posted Aug 5, 2026

Participant flow

Participants recruited from the community through flyers.

Participant flow — Overall Study
MilestonePre-post Single Arm Design
Started5
Completed5
Not completed0

Outcome measures

PrimaryPercentage of Total Confidence

The Measure of Audiologic Rehabilitation Self-Efficacy for Hearing Aids (MARS-HA), referred to as MARSHA, is a 24-item, validated, self-report questionnaire used to assess an individual's confidence (self-efficacy) in their ability to use and manage hearing aids. Participants rated their confidence for each item (0 - 100%) and the average percentage across all items was calculated as the percentage of total confidence. Scores between pre- and post-conditions were compared and reported here.

Time frame:
1 week
Reported as:
Mean · Mean Difference Score on a scale
Percentage of Total Confidence
Mean Difference Score on a scalePre (Unaided)Post (Aided)
Percentage of Total Confidence81.75 ± 8.3191.99 ± 11.60
Statistical analysis
  • Pre (Unaided) ·
SecondaryTotal Readiness Score on the URICA Scale

Participants' readiness to adopt HAs was assessed using the 32-item modified University of Rhode Island Change Assessment (URICA). Each item presents a statement that asks about how ready a person is to move along in their hearing-health journey and adopt a treatment such as HAs. Participants respond to each item using a 5-point scale ranging from strongly disagree (1 point) to strongly agree (5 points). Items represent the stages of change (precontemplation, contemplation, preparation, action). Total readiness score (Readiness for change) is calculated by adding the scores representing the stages contemplation, preparation, action and subtracting this from scores on the items representing the precontemplation stage. The range of total readiness for change score is -2 to 14. Higher score represents higher readiness to adopt HAs, with scores of 11 or more is considered appropriate for someone to have the readiness to taken action to get hearing aids.

Time frame:
1 week
Reported as:
Mean · scores on a scale
Total Readiness Score on the URICA Scale
scores on a scalePre (Unaided)Post (Aided)
Total Readiness Score on the URICA Scale10.63 ± 1.7410.76 ± 1.27
SecondaryHearing Aid Satisfaction on SADL Average Score

The Satisfaction with Amplification in Daily Life (SADL) Scale is a standardized, self-report instrument used to assess patient satisfaction with hearing aid use, including perceived benefit, usability, and psychosocial impact. It has 15 items in 4 subscales (Positive Effect, Service and Cost, Negative Features, Personal Image). For this study, only average score across all items was calculated. For each item participants respond the frequency (how frequently the said outcome in the item happens with them or true for them). Average frequency score (ranging from 1-5) across all items is used for analysis. The range of possible score is 1 to 7. Higher scores indicate greater satisfaction with hearing aids (better outcome). Lower scores indicate lower satisfaction or greater perceived difficulty with hearing aids (poorer outcomes).

Time frame:
1 week
Reported as:
Mean · score on the scale
Hearing Aid Satisfaction on SADL Average Score
score on the scalePre (Unaided)Post (Aided)
Hearing Aid Satisfaction on SADL Average Score4.06 ± 0.824.96 ± 0.84
SecondaryEmotional State Total Score

Participants' change in emotional state will be assessed using the, 20-item, Positive and Negative Affect Schedule-Short Form (PANAS-SF). Participants respond to each item on a 5-point Likert scale ranging from "very slightly or not at all" to "extremely." Participants are asked to read each word and indicate the extent (intensity) to which they feel that way before/after wearing HAs. Positive and negative affective scores will be computed by calculating the sum of the items included for each of these two subscales. For this study, the final emotional state average score was calculated by subtracting the negative state score from the positive state score for each participant. Total possible range of scores would be -40 to +40. A positive emotional state total score indicated that the participant reported greater positive emotional states than negative emotional states.

Time frame:
1 week
Reported as:
Mean · score on the scale
Emotional State Total Score
score on the scalePre (Unaided)Post (Aided)
Emotional State Total Score18.4 ± 0.2217.8 ± 0.24
SecondaryHearing-related Quality of Life Total Score

A one-item hearing-related quality of life question wase used. The question asked about participants' current quality of life compared to before. The scale ranges from "a very great deal worse" (-7) to "a very great deal better" (7). An absolute change of 2 or more is considered clinically relevant in audiology. Higher positive values indicate improvements in hearing- related QOL and higher negative values indicate reduced hearing related QOL.

Time frame:
1 week
Reported as:
Mean · score on the scale
Hearing-related Quality of Life Total Score
score on the scalePre (Unaided)Post (Aided)
Hearing-related Quality of Life Total Score1 ± 2.832.4 ± 3.97

Adverse events

Collected over Through study completion, an average of 1 week. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Pre-post Single Arm Design0/5 (0%)0/5 (0%)0/5 (0%)

Baseline characteristics

There was no difference in these numbers

Age, Continuous
Age, Continuous(years)Pre-post Single Arm Design
Mean71 ± 7.25
Sex/Gender, Customized
Sex/Gender, Customized(Participants)Pre-post Single Arm Design
Gender — Male4
Gender — Female1
Race/Ethnicity, Customized
Race/Ethnicity, Customized(Participants)Pre-post Single Arm Design
Race-Ethnicity — White5
Race-Ethnicity — Black0
Percentage of total confidence
Percentage of total confidence(percentage)Pre-post Single Arm Design
Mean81.75 ± 8.31
08

Study locations

1 site
  • Department of Audiology, University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72204, United States
09

References and documents

Study documents

  • Protocol and statistical analysis plan · Sep 16, 2024

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 5, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT06560918
Lead sponsor
University of Arkansas
Responsible party
Sponsor
First posted
Aug 19, 2024
Start date
Oct 30, 2024
Primary completion
Jan 31, 2026
Completion
Jan 31, 2026
Results posted
Aug 5, 2026
Last update
Aug 5, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion